RISK FACTORS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA

被引：0
|
作者：
Baurmann, H. [1 ]
Collenbusch, F. [1 ]
Schmid, C. [2 ]
Finke, J. [3 ]
Stadler, M. [4 ]
Borubaeuser, M. [5 ]
Schleuning, M. [1 ]
Schwerdtfeger, R. [1 ]
机构：
[1] Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany
[2] Univ Munich, Munich, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Leibniz Univ Hannover, Hannover, Germany
[5] Univ Dresden, Dresden, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2008年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2007.12.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Outcome of allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Thiele, J
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2003, 31 : S108 - S109
  • [2] Myeloablative allogeneic haematopoietic stem cell transplantation for myelofibrosis with myeloid metaplasia
    Ditschkowski, M.
    Keller, M. T.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Koldehoff, M.
    Schulte, C.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S9 - S10
  • [3] Fludarabine reduced conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Hessling, J
    Kroeger, N
    Zabelina, T
    Krüger, W
    Renges, H
    Cordes, U
    Erttmann, R
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S151 - S151
  • [4] Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia
    Hogan W.J.
    Litzow M.R.
    Tefferi A.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 34 - 42
  • [5] Unrelated allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia (MMM)
    Koldehoff, M
    Basara, N
    Lentini, G
    Pohl, H
    Kiehl, MG
    Fauser, AA
    BONE MARROW TRANSPLANTATION, 2002, 29 : S166 - S166
  • [6] Allogeneic stem cell transplantation in myelofibrosis with myeloid metaplasia -: German multicentre analysis supports early transplantation
    Baurmann, H
    Schleuning, M
    Finke, J
    Schmid, C
    Bomhäuser, M
    Gramatzki, M
    Kobbe, G
    Basara, N
    Herr, W
    Massenkeil, G
    Schäfer-Eckart, K
    Beyer, J
    Siegert, W
    Stelljes, M
    Krüger, W
    Hegenbart, U
    Schwerdtfeger, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S66 - S66
  • [7] Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Hessling, J
    Kröger, N
    Werner, M
    Zabelina, T
    Hansen, A
    Kordes, U
    Ayuk, FA
    Renges, H
    Panse, J
    Erttmann, R
    Zander, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 769 - 772
  • [8] Separating patients with myelofibrosis with myeloid metaplasia into risk groups for allogeneic haematopoietic cell transplantation - results of a German multicentre analysis
    Collenbusch, F.
    Schwerdtfeger, R.
    Schleuning, M.
    Schmid, C.
    Finke, J.
    Stadler, M.
    Bornhaeuser, M.
    Messerer-Schmid, D.
    Baurmann, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S52 - S53
  • [9] Allogeneic hematopoietic stem cell transplantation in myelofibrosis with myeloid metaplasia (MMM) - Transplantation should be performed before transfusion dependence occurs
    Baurmann, H
    Burlakowa, I
    Kaltenhaeuser, J
    Judith, D
    Heshmat, M
    Collenbusch, F
    Conradi, R
    Schleuning, M
    Schwerdtfeger, R
    BLOOD, 2004, 104 (11) : 423A - 424A
  • [10] Unrelated hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia.
    Koldehoff, M
    Basara, N
    Kiehl, MM
    Fauser, AA
    BLOOD, 2001, 98 (11) : 385B - 385B
12345